Primary outcomes assessed across these trials were diverse, encompassing insulin metabolism parameters, mental health and metabolic status, HOMA-IR (insulin resistance), vascular endothelial function, and anthropometric indices, alongside lipid profiles, reflecting a broad interest in metabolic, cardiovascular, and psychological endpoints among these patient populations. Here, INS is linked to Insulin resistance.